Clinical Trial Update: Budesonide Orodispersible Tablet vs. Placebo in Active Eosinophilic Esophagitis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing budesonide orodispersible tablets to placebo in active eosinophilic esophagitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• Budesonide Orodispersible Tablet (budesonide)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Eosinophilic Esophagitis | Phase 3 | Status: COMPLETED